mimoleculeindex.com
indexsame ingredientsame route
inspect molecule / umeclidinium and vilanterol ellipta

Umeclidinium And Vilanterol Ellipta

Umeclidinium Bromide
  ___
 /___\
   ||
 breath

Umeclidinium Bromide is the active ingredient anchor for this record. Use the ingredient name before comparing brand, country, or pharmacy prices.

active moietyUmeclidinium Bromide
administration routeRespiratory (Inhalation)
price comparison status2 snapshots
safety signal rating54 / 100
Adrenergic beta2-Agonists [MoA]openFDA NDC seedopenFDA NDC62.5 ug/1
price index

Typical Class Estimates

⚠ Verified price snapshots are queued for this brand/package. Showing typical market estimates based on the drug class: Adrenergic beta2-Agonists [MoA].
$24.50USvsCA$14.20CA

Prices are source-backed snapshots, not medical advice, insurance adjudication, or guaranteed checkout totals.

query trend --id 3770 --12m

Price Trend Index

Deterministic trailing 12-month value delta index for this active ingredient class.

Rising Fast3M: +2.6%12M: +0.4%
Jul 2025
▄▇███▆▃ ▂▅
Jun 2026
Jan 2026$23.84
Feb 2026$23.60
Mar 2026$23.50
Apr 2026$23.45
May 2026$23.73
Jun 2026$24.11
01 / chemistryPrasco Laboratories

Ingredient Breakdown

active moietyUmeclidinium Bromide
formulationRespiratory (Inhalation) Adrenergic beta2-Agonists [MoA]
mechanism of action

Adrenergic beta2-Agonists [MoA]

available strengths
62.5 ug/1

label source: registry ↗

02 / ingredientsexcipients

Excipients / Maker Notes

  • Not enriched yet from label source.

Manufacturer Notes

  • This record is normalized from the openFDA NDC seed. Add DailyMed label extraction before treating manufacturer details as complete.
03 / safetyclinical signals

Steps To Take Safely

  1. Confirm the ingredient and whether the inhaler is rescue, maintenance, or both.
  2. Check priming, spacer, cleaning, and puff-count instructions before first use.
  3. Log frequency of use; high rescue use can be a clinical signal, not just a price issue.
  4. Seek urgent care for severe wheeze, blue lips, confusion, or symptoms not relieved as directed.

Side-Effect Signals

  • label-specific reactions
  • allergic reaction
  • interaction risk
  • dose/formulation confusion
  • urgent symptoms require clinician review
Summary of index signals. Not active medical advice. Consult official labels and clinicians.

$ grep ingredient --same

Same Ingredient Sibling Records

All matches